An annual investment of £35 million into pancreatic cancer would reverse the historic legacy of underfunding and change survival odds.
Increased investment into pancreatic cancer research would accelerate high quality early diagnosis and treatment research and build the infrastructure to establish leadership and collaboration in the pancreatic cancer community. It could also fund more early career fellowships to attract and retain the best talent.
Only through significant and consistent investment can we build the momentum needed and the faster new approaches and treatments will come. Now, more than ever, we need to make sure research funding for pancreatic cancer is prioritised – we cannot afford for research to be set back any further.
Why we know things can change – spotlight on leukaemia
We know that the right level of funding can change everything. For example, there’s been incredible progress in leukaemia thanks to significant and consistent investment. Between 1972 and 2011 survival has quadrupled. Now is the time to make this happen for pancreatic cancer.